Spectrum Pharmaceuticals, Inc. to Present Corporate Update at the RBC Capital Markets Healthcare Conference in New York on February 27th

Published: Feb 20, 2013

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the RBC Capital Markets Healthcare Conference being held at the New York Palace Hotel in New York City. The Company presentation is on Wednesday, February 27, 2013, at 10:00 AM ET.

Back to news